Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase.
暂无分享,去创建一个
T. Morishita | T. Ueda | A. Nakano | H. Uzui | Y. Mitsuke | Toru Geshi | Jong‐Dae Lee | Jong-dae Lee | Hiroyasu Uzui
[1] Lei Zhang,et al. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. , 2011, Cardiovascular research.
[2] T. Morishita,et al. Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus , 2010, Journal of diabetes investigation.
[3] 森本 康嗣. Atorvastatin prevents ischemic limb loss in type 2 diabetes : role of p53 , 2011 .
[4] P. Tsai,et al. Polymorphism of 270 A > G in BRAP is Associated with Lower Ankle-Brachial Index in a Taiwanese Population. , 2011, Journal of atherosclerosis and thrombosis.
[5] B. Gersh,et al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. , 2011, American heart journal.
[6] C. Siu,et al. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. , 2010, The American journal of cardiology.
[7] U. Singh,et al. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. , 2010, Atherosclerosis.
[8] H. Sasai,et al. Is pentraxin 3 involved in obesity-induced decrease in arterial distensibility? , 2010, Journal of atherosclerosis and thrombosis.
[9] H. Ohbayashi,et al. Pitavastatin improves plasma pentraxin 3 and arterial stiffness in atherosclerotic patients with hypercholesterolemia. , 2009, Journal of atherosclerosis and thrombosis.
[10] C. Garlanda,et al. Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis , 2009, Circulation.
[11] Hsiao-Ya Tsai,et al. Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow–Derived Endothelial Progenitor Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[12] N. Fukuda,et al. Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. , 2009, Journal of atherosclerosis and thrombosis.
[13] A. Quyyumi,et al. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. , 2009, American heart journal.
[14] A. Nagler,et al. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. , 2009, The Journal of clinical investigation.
[15] C. Stefanadis,et al. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. , 2008, Atherosclerosis.
[16] H. Matsubara,et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. , 2008, American heart journal.
[17] Pieter Koolwijk,et al. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. , 2008, Cardiovascular research.
[18] C. Garlanda,et al. Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction , 2008, Circulation.
[19] M. Gawaz,et al. Platelet-Derived Stromal Cell–Derived Factor-1 Regulates Adhesion and Promotes Differentiation of Human CD34+ Cells to Endothelial Progenitor Cells , 2008, Circulation.
[20] H. Yoshimatsu,et al. Increased incidence of coronary in-stent restenosis in type 2 diabetic patients is related to elevated serum malondialdehyde-modified low-density lipoprotein. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[21] T. Kodama,et al. Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[22] John V. White,et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[23] A. Avogaro,et al. Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[24] T. Sawamura,et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase Published, JLR Papers in Press, March 7, 2006. , 2006, Journal of Lipid Research.
[25] P. Poole‐Wilson,et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. , 2005, Journal of the American College of Cardiology.
[26] G. Nickenig,et al. Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.
[27] M. Wolzt,et al. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. , 2005, Atherosclerosis.
[28] S. Fichtlscherer,et al. Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.
[29] R. Ferrari,et al. CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004, Circulation.
[30] M. Kutryk,et al. C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function: Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular Disease , 2004, Circulation.
[31] H. Miller,et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. , 2004, European heart journal.
[32] R. Ferrari,et al. CD 34 and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004 .
[33] Yasushi Saito,et al. Increased Circulating Malondialdehyde-Modified LDL Levels in Patients With Coronary Artery Diseases and Their Association With Peak Sizes of LDL Particles , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[34] S. Fichtlscherer,et al. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.
[35] S. Kaul,et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. , 1999, Circulation.
[36] F. Werf,et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.
[37] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[38] T. Blundell,et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. , 1996, Blood.